Search Our Website
Evaluate Your Case Today
Calcagno & Associates
900 South Avenue, 3rd Floor
Staten Island, NY, 10314
Phone: 1-800-WE-FIGHT
(718) 568-3585
By appointment only
Battery Place
New York, NY, 10004
Phone: (800) 933-4448
Grand Concourse Bronx, NY, 10451 Phone: (718) 933-4448
Bay Parkway Brooklyn, NY, 11214 Phone: (800) 487-6837
Cipro, the powerful prescription antibiotic brand made by Bayer, has been linked to painful tendon ruptures, tendinitis, and other severe injuries. Many of the devastating injuries have required extensive surgeries and periods of rehabilitation to repair. In some cases the injuries have left victims permanently disabled and unable to walk or stand without assistance. The reports of injuries prompted the Food and Drug Administration to issue tough new warnings in June 2008 about Cipro and other brands belonging to the fluoroquinolone family of antibiotics.
Patients taking Cipro even for brief periods of time to battle infections have reported suffering sudden and unexpected ruptures of tendons in their feet, hands and arms. The Achilles Tendon in the foot and the rotator cuff of the shoulder have commonly been affected. The reason why the drug leads to an increased risk of tendon injuries is not known.
In addition to tendon ruptures and tendinitis, Cipro users may also experience:
In June 2008, after receiving and investigating wide-spread reports of tendon ruptures and tendinitis in patients taking Cipro, the Food and Drug Administration ordered Bayer to include a prominent “Black Box” warning on the product’s packaging to alert users and physicians of the increased risk of injuries. Black Box warnings are the most severe notice the FDA can order manufacturers to place on a product’s packaging.
If you or a loved one was prescribed the antibiotic Cipro and suffered a tendon rupture or other injury, you may be eligible for financial compensation. Our law firm is available 24/7 to answer any questions you may have. Contact us today for a free, no obligation, legal consultation by completing the case evaluation form on the right side of this page or by calling 1-800-WE-FIGHT (1-800-933-4448).
Return to Defective Drugs Listing